|
WO2021054789A1
|
|
Genetically modified nk cell line transduced with gene encoding novel chimeric antigen receptor and use thereof
|
|
WO2021015584A1
|
|
Method for preparation of immortalized stem cell line and use thereof
|
|
WO2019182422A1
|
|
Novel genetically modified natural killer cell line and use thereof
|
|
WO2019147036A1
|
|
Mesenchymal stem cells expressing brain-derived neurotrophic factor and use thereof
|
|
US2019231862A1
|
|
Gene vaccine for preventing and treating severe fever with thrombocytopenia syndrome
|
|
KR20190042473A
|
|
A gene vaccine for preventing and treating severe fever with thrombocytopenia syndrome
|
|
WO2019027298A2
|
|
Pharmaceutical composition comprising mesenchymal stem cell expressing trail and cd as effective ingredient for prevention or treatment of cancer
|
|
KR20190015153A
|
|
Pharmaceutical composition for preventing or treating vascular diseases comprising mesenchymal stem cell expressing hepatocyte growth factor
|
|
WO2018056736A1
|
|
Novel natural killer cell line and use thereof
|
|
WO2017135795A1
|
|
Mesenchymal stem cell expressing hepatocyte growth factor, and use thereof
|
|
CN109415740A
|
|
Express the mescenchymal stem cell and application thereof of TRAIL and CD
|
|
KR101848252B1
|
|
A composition comprising the Leukodin isolated from the extract of Artemisia Capillaris for skin whitening
|
